When people with low growth hormone fast and take their hormone, their bodies produce less urea (a waste product from breaking down protein), meaning they’re not losing as much protein.
Scientific Claim
In adults with growth hormone deficiency, continuing growth hormone replacement during a 40-hour fast is associated with lower 24-hour urea excretion (269 ± 51 vs. 390 ± 69 mmol/24 h, P < 0.05), indicating reduced nitrogen waste and potentially improved nitrogen conservation.
Original Statement
“During continued GH replacement, urea excretion decreased during nighttime [urea excretion (mmol/24 h): 269 +/- 51 (GH) vs. 390 +/- 69, P < 0.05]”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract reports a statistically significant difference but does not confirm RCT design elements (randomization, blinding). Thus, 'conserves nitrogen' is causal language not fully supported.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether GH replacement consistently reduces urea excretion during fasting across GH-deficient populations, independent of age, sex, or comorbidities.
Whether GH replacement consistently reduces urea excretion during fasting across GH-deficient populations, independent of age, sex, or comorbidities.
What This Would Prove
Whether GH replacement consistently reduces urea excretion during fasting across GH-deficient populations, independent of age, sex, or comorbidities.
Ideal Study Design
A meta-analysis of 6+ randomized crossover trials in adults with confirmed hypopituitarism (n≥120 total), comparing 24-hour urea excretion during 40-hour fasts with and without GH replacement, using standardized dietary and metabolic controls.
Limitation: Cannot determine if reduced urea translates to long-term muscle preservation or clinical benefit.
Randomized Controlled TrialLevel 1bWhether GH replacement causally reduces urea excretion during fasting in GH-deficient adults.
Whether GH replacement causally reduces urea excretion during fasting in GH-deficient adults.
What This Would Prove
Whether GH replacement causally reduces urea excretion during fasting in GH-deficient adults.
Ideal Study Design
A double-blind, randomized, crossover RCT with 25+ GH-deficient adults, each undergoing two 40-hour fasts (GH vs. placebo), with 24-hour urine collection for urea-N quantification, and nitrogen balance calculated from intake and excretion.
Limitation: Short-term; does not assess long-term muscle mass or functional outcomes.
Prospective Cohort StudyLevel 2bWhether long-term GH users have lower urea excretion during fasting compared to non-users in real-world settings.
Whether long-term GH users have lower urea excretion during fasting compared to non-users in real-world settings.
What This Would Prove
Whether long-term GH users have lower urea excretion during fasting compared to non-users in real-world settings.
Ideal Study Design
A prospective cohort of 100+ GH-deficient adults monitored over 1 year, measuring 24-hour urea excretion during medically indicated fasts, comparing those on continuous GH vs. those who discontinued, adjusting for diet, renal function, and BMI.
Limitation: Confounding by adherence, diet, or other medications may bias results.
Evidence from Studies
Supporting (1)
Continuation of Growth Hormone (GH) Substitution during Fasting in GH-Deficient Patients Decreases Urea Excretion and Conserves Protein Synthesis<sup>1</sup>
When people with low growth hormone fast, giving them their hormone medicine helps their bodies hold onto protein better and produce less waste (urea), which is exactly what the claim says.